Stephen J. Tulipano, CFO at Stoke Therapeutics, Inc. (STOK), sold 139,600 shares at $41.42 ($5.4M) on 2020-11-04, disclosed to the SEC on 2020-11-04.
Open-market sale of $5.4M STOK by CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.79 | 20,155 | $742K | 13.6% |
| 2 | $36.79 | 20,155 | $742K | 13.6% |
| 3 | $37.86 | 14,445 | $547K | 10.0% |
| 4 | $37.86 | 14,445 | $547K | 10.0% |
| 5 | $38.44 | 400 | $15K | 0.3% |
| 6 | $39.84 | 1,732 |
| $69K |
| 1.3% |
| 7 | $39.84 | 1,732 | $69K | 1.3% |
| 8 | $40.03 | 16,941 | $678K | 12.5% |
| 9 | $40.03 | 16,941 | $678K | 12.5% |
| 10 | $41.42 | 11,111 | $460K | 8.5% |
| 11 | $41.42 | 11,111 | $460K | 8.5% |
| 12 | $41.97 | 5,216 | $219K | 4.0% |
| 13 | $41.97 | 5,216 | $219K | 4.0% |
| Total | $39.00 avg | 139,600 | $5.4M | 100% |
| Filing → |
| ALDX | BUY | 2017-02-21 | $15K | — | Filing → |
| JAV | SELL | 2010-05-05 | $5K | — | Filing → |